Beadnell, T. C., Mishall, K. M., Zhou, Q., Riffert, S. M., Wuensch, K. E., Kessler, B. E., . . . Schweppe, R. E. (2016). The Mitogen Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor, Dasatinib, in Thyroid Cancer. Mol Cancer Ther.
Citación estilo ChicagoBeadnell, Thomas C., et al. "The Mitogen Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor, Dasatinib, in Thyroid Cancer." Mol Cancer Ther 2016.
Cita MLABeadnell, Thomas C., et al. "The Mitogen Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor, Dasatinib, in Thyroid Cancer." Mol Cancer Ther 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.